99 related articles for article (PubMed ID: 15738652)
1. Histone deacetylase inhibitors in programmed cell death and cancer therapy.
Marks PA; Jiang X
Cell Cycle; 2005 Apr; 4(4):549-51. PubMed ID: 15738652
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor.
Xu W; Ngo L; Perez G; Dokmanovic M; Marks PA
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15540-5. PubMed ID: 17030815
[TBL] [Abstract][Full Text] [Related]
3. The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation.
Samuni Y; Flores-Santana W; Krishna MC; Mitchell JB; Wink DA
Free Radic Biol Med; 2009 Aug; 47(4):419-23. PubMed ID: 19447172
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation.
Yang F; Sun S; Wang C; Haas M; Yeo S; Guan JL
Br J Cancer; 2020 Jun; 122(12):1791-1802. PubMed ID: 32336756
[TBL] [Abstract][Full Text] [Related]
5. Role of Epigenetics for the Efficacy of Cisplatin.
Lumpp T; Stößer S; Fischer F; Hartwig A; Köberle B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256203
[TBL] [Abstract][Full Text] [Related]
6. The potential of activator protein 1 (AP-1) in cancer targeted therapy.
Song D; Lian Y; Zhang L
Front Immunol; 2023; 14():1224892. PubMed ID: 37483616
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.
Valdez BC; Nieto Y; Yuan B; Murray D; Andersson BS
Oncotarget; 2022 Oct; 13():1122-1135. PubMed ID: 36243940
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Retinoid Kills Drug-Resistant Cancer Stem Cells via Inducing RARγ-Translocation-Mediated Tension Reduction and Chromatin Decondensation.
Zhang Y; Dong Q; An Q; Zhang C; Mohagheghian E; Niu B; Qi F; Wei F; Chen S; Chen X; Wang A; Cao X; Wang N; Chen J
Adv Sci (Weinh); 2022 Nov; 9(31):e2203173. PubMed ID: 36031407
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy.
Trojaniello C; Luke JJ; Ascierto PA
Front Oncol; 2021; 11():670726. PubMed ID: 34178657
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.
Gerbeth L; Glauben R
Front Med (Lausanne); 2021; 8():655956. PubMed ID: 33842512
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies.
Sztiller-Sikorska M; Czyz M
Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32823992
[TBL] [Abstract][Full Text] [Related]
12. Microglia: Agents of the CNS Pro-Inflammatory Response.
Rodríguez-Gómez JA; Kavanagh E; Engskog-Vlachos P; Engskog MKR; Herrera AJ; Espinosa-Oliva AM; Joseph B; Hajji N; Venero JL; Burguillos MA
Cells; 2020 Jul; 9(7):. PubMed ID: 32709045
[TBL] [Abstract][Full Text] [Related]
13. Loci specific epigenetic drug sensitivity.
Zhang T; Pilko A; Wollman R
Nucleic Acids Res; 2020 May; 48(9):4797-4810. PubMed ID: 32246716
[TBL] [Abstract][Full Text] [Related]
14. New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.
Fujii K
Front Oncol; 2018; 8():198. PubMed ID: 29915722
[TBL] [Abstract][Full Text] [Related]
15. The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis.
Ali MN; Choijookhuu N; Takagi H; Srisowanna N; Nguyen Nhat Huynh M; Yamaguchi Y; Synn Oo P; Tin Htwe Kyaw M; Sato K; Yamaguchi R; Hishikawa Y
Acta Histochem Cytochem; 2018 Feb; 51(1):33-40. PubMed ID: 29622848
[TBL] [Abstract][Full Text] [Related]
16. AP-1 confers resistance to anti-cancer therapy by activating XIAP.
Wang Y; Wan GH; Wu YM; Wang HS; Wang HF; Zhang G; Lu LL; Li ZQ; Chan KY; Zhou Y; Cai SH; Qi YF; Du J
Oncotarget; 2018 Mar; 9(18):14124-14137. PubMed ID: 29581832
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil potentiates sodium butyrate induced preconditioning of neurons and enhances their survival upon subsequent treatment with H
Tabeshmehr P; Husnain HK; Salmannejad M; Sani M; Hosseini SM; Khorraminejad Shirazi MH
Transl Neurodegener; 2017; 6():29. PubMed ID: 29093814
[TBL] [Abstract][Full Text] [Related]
18. Suberoylanilide hydroxamic acid sensitizes neuroblastoma to paclitaxel by inhibiting thioredoxin-related protein 14-mediated autophagy.
Zhen Z; Yang K; Ye L; You Z; Chen R; Liu Y; He Y
Cancer Sci; 2017 Jul; 108(7):1485-1492. PubMed ID: 28498513
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cells.
Chun SM; Lee JY; Choi J; Lee JH; Hwang JJ; Kim CS; Suh YA; Jang SJ
PLoS One; 2015; 10(3):e0119379. PubMed ID: 25781604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
